Latest Capital Raise News

Clara Resources Australia Limited has announced a fully underwritten entitlement offer to raise approximately $1.27 million, aimed at funding drilling and development activities at its Ashford Coking Coal project. The offer follows a recent placement and includes a shortfall facility for eligible shareholders.

Clara Resources Australia Ltd has raised $1.6 million through a placement and a fully underwritten rights issue, aiming to accelerate development of its Ashford Coking Coal Project in New South Wales.

Sky Metals reports significant drilling successes and metallurgical advances at its Tallebung and Doradilla tin projects, supported by a $6.1 million capital raise to accelerate development.

Freehill Mining Limited has increased its capital raising to $540,000 through a share placement and free-attaching options, aiming to support its processing operations in Chile and strengthen working capital.

Radiopharm Theranostics has announced a $40 million equity raise via a two-tranche placement and a Share Purchase Plan (SPP) to fund its clinical programs and working capital. The offer includes new shares at $0.03 each with free attaching options, subject to shareholder approval.

United States Antimony Corporation has proposed acquiring Larvotto Resources in a deal that could create one of the largest antimony producers outside China, offering Larvotto shareholders a significant premium.

Avira Resources has secured a binding agreement to acquire the high-grade Mt Cattlin Gold Project in Western Australia, backed by a $2.5 million capital raise to advance exploration and resource development.

Flynn Gold Limited has reported significant progress in its Tasmanian gold exploration projects, including new high-grade gold discoveries and a successful $5 million capital raise to fund further drilling and development.

Southern Palladium has raised A$20 million through a strategic share placement to accelerate its Bengwenyama PGM project, positioning the company for key milestones including a Final Investment Decision in 2026.

Jindalee Lithium has launched an options offer linked to its recent Share Purchase Plan and placements, aiming to incentivize shareholders and raise capital for its lithium development projects. The options carry an exercise price of $0.825 and expire in late 2028.

Jindalee Lithium has successfully raised $8 million through a private placement, complemented by a $1 million Share Purchase Plan, to advance its McDermitt Lithium Project and a strategic US SPAC transaction.

BCAL Diagnostics has launched a $10 million convertible note facility, with $5 million already committed, to strengthen its capital position and accelerate commercialisation of its cancer detection technologies.